Favourites   Have ideas?  Sign in / Register

Positive:   Cannabis ↓10.68   Disease: Spinal ↓9.74   Fibrosis ↓9.74 «See more»   Biology ↑3.08   Country: Canada ↑4.25   Country: Israel ↑7.93

Negative:   Bad infrastructure  ↑0.56


Disease: Oncology segment

APVO Aptevo Therapeutics Inc. - Common Stock 5% down 18.12% -13.12 + Biotechnology, Medicine, Disease: Oncology, Immunology


Last highlighted: $APVTW [15s. delayed] filed form 8-K on May 27, 09:02:28: Item7.01: Regulation FD https://t.co/MpE2r05xab
+ My List
ARAY Accuray Incorporated - Common Stock -4.35% -4.35% 0 + Disease: Oncology, Medicine, Equipment, Manufacturing


Last highlighted: $ARAY 📜 Accuray Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits https://t.co/48zqtD0zRx #healthcare
+ My List
ARVN Arvinas, Inc. - Common Stock 2.37% down 10.58% -8.21 + Disease: Neuropsychiatric, Medicine, Disease: Oncology


Last highlighted: #ARVN SEC report: ARVINAS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ARVINAS, INC. -- SEC File Number 211148061
+ My List
AVEO AVEO Pharmaceuticals, Inc. - Common Stock 0.75% down 10% -9.25 + Medicine, Disease: Oncology, Cancer fight


Last highlighted: #AVEO SEC report: AVEO PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by AVEO PHARMACEUTICALS, INC. -- SEC File Number 211148137
+ My List
CTMX CytomX Therapeutics, Inc. - Common Stock 0.56% down 7.41% -6.85 + Biopharma, Cancer fight, Disease: Oncology
- Bad infrastructure
+ My List
GNPX Genprex, Inc. - Common Stock -3.21% down 16.03% -19.24 + Cancer fight, Disease: Oncology, Medicine


Last highlighted: $GNPX [15s. delayed] filed form 10-Q on August 13, 16:34:15 https://t.co/cEVufMKwcd
+ My List
GTH Genetron Holdings Limited - American Depositary Shares 4.93% down 10.16% -5.23 + Cancer fight, Medicine, Disease: Oncology, Country: China


Last highlighted: $GTH / Genetron Holdings Limited ADS files form 6-K https://t.co/3DehdripqL
+ My List
HCM Hutchison China MediTech Limited - American Depositary Shares -13.24% -13.24% 0 + Country: China, Medicine, Disease: Oncology, Cancer fight


Last highlighted: $HCM 📜 SEC Form 6-K filed by Hutchison China MediTech Limited https://t.co/3MQ4DYnXFz 15s delayed.
+ My List
IMTX Immatics N.V. - Ordinary Shares 5.51% up -12.79% 18.3 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
INMB INmune Bio Inc. - Common stock -7.19% -7.19% 0 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock 1.15% down 8.46% -7.31 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
ITOS iTeos Therapeutics, Inc. - Common Stock -8.59% -8.59% 0 + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine


Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement https://t.co/fsH6i8bthL 15s delayed.
+ My List
KPTI Karyopharm Therapeutics Inc. - Common Stock up -10.02% 10.02 + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine


Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number
+ My List
MOR MorphoSys AG - American Depositary Shares -9.41% -9.41% 0 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight

+ My List
NCNA NuCana plc - American Depositary Shares 0 + Cancer fight, Disease: Oncology, Medicine

+ My List
ONCS OncoSec Medical Incorporated - Common Stock 0 + Cancer fight, Disease: Oncology, Medicine, Immunology


Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number
+ My List
ORIC Oric Pharmaceuticals, Inc. - Common Stock -7.43% -7.43% 0 + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight


Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899
+ My List
PDSB PDS Biotechnology Corporation - Common Stock 3.28% down 11.36% -8.08 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
+ My List
QTRX Quanterix Corporation - Common Stock up -8.08% 8.08 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology


Last highlighted: #QTRX SEC report: Quanterix Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Quanterix Corp -- SEC File Number
+ My List
SRRK Scholar Rock Holding Corporation - Common Stock -9.74% -9.74% 0 + Medicine, Disease: Spinal, Disease: Oncology, Fibrosis


Last highlighted: #SRRK SEC report: Scholar Rock Holding Corp Current report, items 5.02, 7.01, and 9.01
SEC Filing Form 8-K filed by Scholar Rock Holding Corp -- SEC File Number 211137996
+ My List
TCON TRACON Pharmaceuticals, Inc. - Common Stock -1.54% down 13.53% -15.07 + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology

+ My List
TLC Taiwan Liposome Company, Ltd. - American Depositary Shares 0.00% 0 + Country: Taiwan, Medicine, Pain fight, Disease: Oncology, Disease: Infectious, Ophthalmology


Last highlighted: #TLC SEC report: Taiwan Liposome Company, Ltd. Appointment of Agent for Service of Process and Undertaking
SEC Filing Form F-X filed by Taiwan Liposome Company, Ltd. -- SEC File Number 211147635
+ My List
TRIL Trillium Therapeutics Inc. - Common Shares 0.00% 0 + Country: Canada, Cancer fight, Disease: Oncology, Immunology


Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number
+ My List
XBIO Xenetic Biosciences, Inc. - Common Stock 0 + Biopharma, Cancer fight, Disease: Oncology, Medicine

+ My List
ZIOP ZIOPHARM Oncology Inc - Common Stock -8.18% -8.18% 0 + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine

+ My List
BCTX BriaCell Therapeutics Corp. - Common Shares 6.3% up -8.37% 14.67 + Cancer fight, Immunology, Medicine, Disease: Oncology


Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540
+ My List
BOLT Bolt Biotherapeutics, Inc. - Common Stock -9.36% -9.36% 0 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
ENVB Enveric Biosciences, Inc. - Common Stock -10.68% -10.68% 0 + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology


Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155
+ My List
EVAX Evaxion Biotech A/S - American Depositary Share 6.15% down 7.45% -1.3 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology


Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935
+ My List
FSTX F-star Therapeutics, Inc. - Common Stock -7.23% -7.23% 0 + Immunology, Medicine, Cancer fight, Disease: Oncology


Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number
+ My List
GTBP GT Biopharma, Inc. - Common Stock 15.42% 15.42% 0 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight


Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131
+ My List
LIXT Lixte Biotechnology Holdings, Inc. - Common Stock up -19.83% 19.83 + Biotechnology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663
+ My List
PPBT Purple Biotech Ltd. - American Depositary Shares 7.93% up 6.55% 1.38 + Country: Israel, Cancer fight, Disease: Oncology

+ My List
PRTG Portage Biotech Inc. - Common Stock 8.5% 8.5% 0 + Country: Canada, Immunology, Cancer fight, Disease: Oncology

+ My List
SBTX Silverback Therapeutics, Inc. - Common Stock 7.07% 7.07% 0 + Cancer fight, Disease: Oncology, Disease: Infectious, Medicine

+ My List
SCPS Scopus BioPharma Inc. - Common Stock 0 + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma


Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB
+ My List
VOR Vor Biopharma Inc. - Common Stock -4.3% up -7.25% 2.95 + Biopharma, Medicine, Cancer fight, Disease: Oncology

+ My List
IKNA Ikena Oncology, Inc. - Common Stock -14.29% -14.29% 0 + Cancer fight, Disease: Oncology, Medicine

+ My List
LVTX LAVA Therapeutics N.V. - Ordinary Shares -7.1% -7.1% 0 + T cell-based, Cancer fight, Medicine, Disease: Oncology

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.